| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |